Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ABCG2 | Q9UNQ0 | 6/20 | 0.33 |
| ▸ | ABCB1 | P08183 | 3/20 | 0.33 |
| ▸ | NR3C1 | P04150 | 1/20 | 0.32 |
| ▸ | PGR | P06401 | 1/20 | 0.32 |
| ▸ | PIK3CD | O00329 | 1/20 | 0.32 |
| ▸ | PIK3CA | P42336 | 1/20 | 0.32 |
| ▸ | STS | P08842 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | HPGD | P15428 | 1/20 | 0.32 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
| ▸ | ABCC1 | P33527 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21364936 | 0.96 | CYP1A2 (0.36) | ABCG2NR3C1ALDH1A1LMNAHPGD | |
| SCHEMBL22243128 | 0.95 | NR3C1 (0.34) | ABCG2ABCB1NR3C1STSALDH1A1 | |
| SCHEMBL21364531 | 0.95 | NR3C1 (0.38) | ABCG2ABCB1NR3C1STSALDH1A1 | |
| SCHEMBL21364360 | 0.94 | ABCG2 (0.37) | ABCG2ABCB1PGRPIK3CDPIK3CA | |
| SCHEMBL22243127 | 0.93 | PTGER4 (0.33) | ABCG2ABCB1NR3C1STSALDH1A1 | |
| SCHEMBL21364860 | 0.93 | ABCG2 (0.37) | ABCG2ABCB1PGRPIK3CDPIK3CA | |
| SCHEMBL22243126 | 0.93 | ABCG2 (0.37) | ABCG2ABCB1PGRPIK3CDPIK3CA | |
| SCHEMBL21364975 | 0.92 | ABCG2 (0.36) | ABCG2ABCB1STSALDH1A1LMNA | |
| SCHEMBL22243164 | 0.92 | ABCG2 (0.35) | ABCG2ABCB1PGRPIK3CDPIK3CA | |
| SCHEMBL21364371 | 0.91 | ABCG2 (0.35) | ABCG2ABCB1PGRPIK3CDPIK3CA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11161836-B2 | Organic molecules for optoelectronic devices | CYNORA GMBH (DE) | 2021-11-02 | — | — | US | disclosed |
| US-20190284174-A1 | ORGANIC MOLECULES FOR OPTOELECTRONIC DEVICES | SAMSUNG DISPLAY CO., LTD. (KR) | 2019-09-19 | — | — | US | disclosed |
| EP-3540808-A1 | ORGANIC MOLECULES, IN PARTICULAR FOR USE IN OPTOELECTRONIC DEVICES | CYNORA GMBH (DE) | 2019-09-18 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190284174-A1 | ORGANIC MOLECULES FOR OPTOELECTRONIC DEVICES | OR10J3, OR51E2, OCIAD2 | ABCG2 3275/4885ABCB1 1278/4885NR3C1 4626/4885 |
| US-11161836-B2 | Organic molecules for optoelectronic devices | OR10J3, OR51E2, OCIAD2 | ABCG2 3275/4885ABCB1 1278/4885NR3C1 4626/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.